{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008605","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.416332+00:00","generated_at":"2026-05-15T21:58:27.509786+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Protagenic Therapeutics appoints William Nichols as President; base salary $350k, 40% bonus target, 1% option grant","bullets":["William (Bill) Nichols, Jr., age 51, appointed President effective Feb 3, 2026.","Prior senior commercial leadership roles at bluebird bio, Dova Pharmaceuticals, and Bristol-Myers Squibb.","Annual base salary $350,000; eligible for annual target bonus of 40% of base salary.","Employment agreement includes option grant equal to ~1.0% of fully diluted share count.","No family relationships or transactions requiring Item 404(a) disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008605","json":"https://secwatch.observer/filing/0001493152-26-008605.json","markdown":"https://secwatch.observer/filing/0001493152-26-008605.md","text":"https://secwatch.observer/filing/0001493152-26-008605.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315226008605/0001493152-26-008605-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315226008605/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:58:27.509786+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}